Sustainability-led
Business Commitment

Strengthening positive impact and delivering values

Since 2016, when we started our ESG journey, we have taken steps to reduce our emissions and environmental impact and improve the sustainability of our manufacturing process and materials. We have maintained and improved our ability to provide consumers and patients with access to the medicines and therapies they need for better health. We have also strengthened our team diversity to promote more inclusive perspectives, as well as refined our management system and corporate culture.

.

Duopharma Biotech’s Commitment and Aspirations

We acknowledge that achieving sustainable business is a progressive transition that requires continuous commitments and efforts. To catalyse this process, we have established a 5-year ESG Strategy that will be fully embedded in our business operations and drive key initiatives. Our ESG Strategy is distributed across the three pillars of Environment, Social and Governance, and underpinned by 5 Key Focus Areas – Climate Performance, Sustainable Supply Chain, Access to Medicine, Diversity & Inclusion and Governance.

We understand the imperative need to align and embed our sustainability strategy with overall business strategy – an area we plan to further refine in the near future. This includes the integration of climate-related risks into business risks that will strengthen our business strategy and increase business resilient. We also anticipate to align our process and disclosures to the Task Force on Climate-related Financial Disclosures (TCFD) recommendations – that will help us to further understand and quantify the financial impact of climate-related risks and opportunities.

ESG Governance
& Policies